Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madsbad

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Ugeskrift for Laeger|July 22, 1991
[A proposal on the structuring of thyroid surgery and patient examination in Denmark]J M Hansen, U Feldt-Rasmussen, C Kirkegaard, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2011
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and menS B Haugaard, O Andersen, T W Hansen, et al.
Diabetologia|September 29, 2011
Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individualsK S Burgdorf, A P Gjesing, N Grarup, et al.
Ugeskrift for Laeger|March 6, 1978
[Hepatitis B among Danish dentists]J Aldershvile, A Brock, O Dietrichson, et al.
The Journal of Infectious Diseases|January 1, 1978
Hepatitis B virus infections among Danish dentistsJ Aldershvile, A Brock, O Dietrichson, et al.
Diabetologia|May 1, 2009
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interactionT Sparsø, N Grarup, C Andreasen, et al.
Diabetologia|June 24, 2008
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulationT Sparsø, G Andersen, A Albrechtsen, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2009
Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesisN Ejskjaer, E T Vestergaard, P M Hellström, et al.
Obesity Science & Practice|December 21, 2017
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoBL Engelbrechtsen, J Lundgren, N J Wewer Albrechtsen, et al.
Clinical Endocrinology|September 22, 2016
Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypassS G Vienberg, S H Jacobsen, D Worm, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Ugeskrift for Laeger|July 22, 1991
[A proposal on the structuring of thyroid surgery and patient examination in Denmark]J M Hansen, U Feldt-Rasmussen, C Kirkegaard, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2011
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and menS B Haugaard, O Andersen, T W Hansen, et al.
Diabetologia|September 29, 2011
Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individualsK S Burgdorf, A P Gjesing, N Grarup, et al.
Ugeskrift for Laeger|March 6, 1978
[Hepatitis B among Danish dentists]J Aldershvile, A Brock, O Dietrichson, et al.
The Journal of Infectious Diseases|January 1, 1978
Hepatitis B virus infections among Danish dentistsJ Aldershvile, A Brock, O Dietrichson, et al.
Diabetologia|May 1, 2009
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interactionT Sparsø, N Grarup, C Andreasen, et al.
Diabetologia|June 24, 2008
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulationT Sparsø, G Andersen, A Albrechtsen, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2009
Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesisN Ejskjaer, E T Vestergaard, P M Hellström, et al.
Obesity Science & Practice|December 21, 2017
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoBL Engelbrechtsen, J Lundgren, N J Wewer Albrechtsen, et al.
Clinical Endocrinology|September 22, 2016
Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypassS G Vienberg, S H Jacobsen, D Worm, et al.
Pageof 23